Reporting owner · Q3 2026 · CIK 1087939

Baker Julian: insider trades.

Baker Julian reported 88 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 82 open-market purchases ($157.0M) and 2 sales ($317.8M), across 4 companies.

Transactions
88
Purchases (P)
82
Sales (S)
2
Companies
4
Name as filed
BAKER JULIAN

Companies

CompanyRelationshipTransactions
Kodiak Sciences Inc. (KOD)Director, TenPercentOwner82
BeOne Medicines Ltd. (ONC)Director2
Celcuity Inc. (CELC)Other2
Incyte Corp (INCY)Director, TenPercentOwner2

Transactions

88 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-29Kodiak Sciences Inc.P1,416$85.8920,191,214Form 4
2026-09-29Kodiak Sciences Inc.P619$84.241,668,448Form 4
2026-09-29Kodiak Sciences Inc.P10,381$84.2420,169,767Form 4
2026-09-29Kodiak Sciences Inc.P1,195$85.41,669,643Form 4
2026-09-29Kodiak Sciences Inc.P20,031$85.420,189,798Form 4
2026-09-29Kodiak Sciences Inc.P84$85.891,669,727Form 4
2026-09-28Kodiak Sciences Inc.P856$61.211,561,270Form 4
2026-09-28Kodiak Sciences Inc.P4,067$62.9618,421,873Form 4
2026-09-28Kodiak Sciences Inc.P2,666$61.631,563,936Form 4
2026-09-28Kodiak Sciences Inc.P44,690$61.6318,417,806Form 4
2026-09-28Kodiak Sciences Inc.P4,577$73.971,594,434Form 4
2026-09-28Kodiak Sciences Inc.P76,723$73.9718,929,052Form 4
2026-09-28Kodiak Sciences Inc.P1,924$75.521,596,358Form 4
2026-09-28Kodiak Sciences Inc.P32,261$75.5218,961,313Form 4
2026-09-28Kodiak Sciences Inc.P3,681$76.351,600,039Form 4
2026-09-28Kodiak Sciences Inc.P61,700$76.3519,023,013Form 4
2026-09-28Kodiak Sciences Inc.P2,884$77.431,602,923Form 4
2026-09-28Kodiak Sciences Inc.P48,350$77.4319,071,363Form 4
2026-09-28Kodiak Sciences Inc.P2,969$78.571,605,892Form 4
2026-09-28Kodiak Sciences Inc.P49,771$78.5719,121,134Form 4
2026-09-28Kodiak Sciences Inc.P479$64.431,564,658Form 4
2026-09-28Kodiak Sciences Inc.P278,978$72.3918,773,603Form 4
2026-09-28Kodiak Sciences Inc.P4,696$73.081,589,857Form 4
2026-09-28Kodiak Sciences Inc.P78,726$73.0818,852,329Form 4
2026-09-28Kodiak Sciences Inc.P8,021$64.4318,429,894Form 4
2026-09-28Kodiak Sciences Inc.P243$62.961,564,179Form 4
2026-09-28Kodiak Sciences Inc.P16,641$72.391,585,161Form 4
2026-09-28Kodiak Sciences Inc.P17,698$71.4818,494,625Form 4
2026-09-28Kodiak Sciences Inc.P1,056$71.481,568,520Form 4
2026-09-28Kodiak Sciences Inc.P39,066$68.9618,476,927Form 4
2026-09-28Kodiak Sciences Inc.P2,331$68.961,567,464Form 4
2026-09-28Kodiak Sciences Inc.P2,585$68.3718,437,861Form 4
2026-09-28Kodiak Sciences Inc.P154$68.371,565,133Form 4
2026-09-28Kodiak Sciences Inc.P5,382$67.118,435,276Form 4
2026-09-28Kodiak Sciences Inc.P321$67.11,564,979Form 4
2026-09-28Kodiak Sciences Inc.P14,344$61.2118,373,116Form 4
2026-09-28Kodiak Sciences Inc.P1,024$81.021,608,816Form 4
2026-09-28Kodiak Sciences Inc.P17,159$81.0219,170,169Form 4
2026-09-28Kodiak Sciences Inc.P338$81.21,609,154Form 4
2026-09-28Kodiak Sciences Inc.P5,654$81.219,175,823Form 4
2026-09-28Kodiak Sciences Inc.P1,044$81.311,610,198Form 4
2026-09-28Kodiak Sciences Inc.P17,490$81.3119,193,313Form 4
2026-09-28Kodiak Sciences Inc.P1,027$80.5219,153,010Form 4
2026-09-28Kodiak Sciences Inc.P61$80.521,607,792Form 4
2026-09-28Kodiak Sciences Inc.P6,783$80.2319,151,983Form 4
2026-09-28Kodiak Sciences Inc.P404$80.231,607,731Form 4
2026-09-28Kodiak Sciences Inc.P14,827$79.7119,145,200Form 4
2026-09-28Kodiak Sciences Inc.P884$79.711,607,327Form 4
2026-09-28Kodiak Sciences Inc.P283$79.6319,130,373Form 4
2026-09-28Kodiak Sciences Inc.P17$79.631,606,443Form 4
2026-09-28Kodiak Sciences Inc.P8,956$79.419,130,090Form 4
2026-09-28Kodiak Sciences Inc.P534$79.41,606,426Form 4
2026-09-28Kodiak Sciences Inc.P38,932$85.9719,515,907Form 4
2026-09-28Kodiak Sciences Inc.P2,322$85.971,629,442Form 4
2026-09-28Kodiak Sciences Inc.P109,842$84.8519,476,975Form 4
2026-09-28Kodiak Sciences Inc.P6,553$84.851,627,120Form 4
2026-09-28Kodiak Sciences Inc.P123,888$83.9519,367,133Form 4
2026-09-28Kodiak Sciences Inc.P7,390$83.951,620,567Form 4
2026-09-28Kodiak Sciences Inc.P19,554$83.1619,243,245Form 4
2026-09-28Kodiak Sciences Inc.P1,167$83.161,613,177Form 4
2026-09-28Kodiak Sciences Inc.P1,699$82.6819,223,691Form 4
2026-09-28Kodiak Sciences Inc.P101$82.681,612,010Form 4
2026-09-28Kodiak Sciences Inc.P651$81.9219,221,992Form 4
2026-09-28Kodiak Sciences Inc.P39$81.921,611,909Form 4
2026-09-28Kodiak Sciences Inc.P1,672$81.821,611,870Form 4
2026-09-28Kodiak Sciences Inc.P28,028$81.8219,221,341Form 4
2026-09-28Kodiak Sciences Inc.P186$86.721,629,628Form 4
2026-09-28Kodiak Sciences Inc.P3,114$86.7219,519,021Form 4
2026-09-28Kodiak Sciences Inc.P957$86.811,630,585Form 4
2026-09-28Kodiak Sciences Inc.P16,036$86.8119,535,057Form 4
2026-09-28Kodiak Sciences Inc.P3,790$86.941,634,375Form 4
2026-09-28Kodiak Sciences Inc.P63,539$86.9419,598,596Form 4
2026-09-28Kodiak Sciences Inc.P4,485$87.511,638,860Form 4
2026-09-28Kodiak Sciences Inc.P75,176$87.5119,673,772Form 4
2026-09-28Kodiak Sciences Inc.P5,880$88.571,644,740Form 4
2026-09-28Kodiak Sciences Inc.P98,561$88.5719,772,333Form 4
2026-09-28Kodiak Sciences Inc.P6,428$88.651,651,168Form 4
2026-09-28Kodiak Sciences Inc.P107,772$88.6519,880,105Form 4
2026-09-28Kodiak Sciences Inc.P4,932$89.61,656,100Form 4
2026-09-28Kodiak Sciences Inc.P82,673$89.619,962,778Form 4
2026-09-28Kodiak Sciences Inc.P11,729$89.861,667,829Form 4
2026-09-28Kodiak Sciences Inc.P196,608$89.8620,159,386Form 4
2026-09-14BeOne Medicines Ltd.M30,768$36.838,099,179Form 4
2026-09-14BeOne Medicines Ltd.M30,768$36.83761,410Form 4
2026-07-14Celcuity Inc.S2,838,632$102.54,372,852Form 4
2026-07-14Celcuity Inc.S261,368$102.5442,940Form 4
2026-06-30Incyte CorpA400$02,835,081Form 4
2026-06-30Incyte CorpA400$028,205,760Form 4

Questions

What stock did Baker Julian buy or sell?

Baker Julian reported 88 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 82 open-market purchases ($157.0M) and 2 sales ($317.8M), across 4 companies.

Is Baker Julian the same person as other filers with this name?

This page covers SEC CIK 1087939 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/baker-julian-1087939.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.